Search results for Genomic Medicine

Operationalizing Precision Medicine 2026: U.S. Health Systems Scale Genetic Testing and AI Integration 

What You Should Know Precision medicine has transitioned from “one-off” testing to organized institutional programs at more than three-quarters of surveyed U.S. health systems, acc...

It’s time to take genetic testing off the pedestal 

For years, genetic testing has been treated as something rare and exceptional—a highly specialized tool ordered only by geneticists and often reserved for the end of a long diagnos...

Rapid genomic testing helps 1,100 families worldwide target treatment for rare childhood disease

An international partnership designed to improve equality in access to genomic medicine for a rare disease has now provided potentially life-saving genetic testing for over 1,100 f...

Genetic Medicine Delivery Enhanced by Producer Cell Modifications

A new platform based on genome-wide screening systemically identifies which genes drive or block particle assembly to engineer cells that yield more potent delivery vehicles.  The...

Life Science Update | March 2026

Advances in AI and genomic analysis will allow medical providers to tailor treatment for individual patients at the genome level, but challenges exist for protecting AI-assisted in...

The $80,000 clue hiding in plain sight in U.S. healthcare

American healthcare faces a persistent paradox: We have extraordinary medical technology, yet patients often spend years navigating a system that treats symptoms before identifying...

The Conversation: Tapping Your Genome With AI And Quantum Computing Could Deliver on The Promise of Personalized Medicin...

From The Conversation By Gary Skuse, Professor of Bioinformatics, Rochester Institute of Technology and Sherry Dadgar, Clinical Assistant Professor of Medicine, George Washington U...

Gene Editing at Scale, Clinic Seeks Generalizable Therapies

What’s most exciting about CRISPR is its potential to shift medicine from managing disease to directly correcting its root cause. End-to-end pipelines and regulatory advances aim t...

Medgenome unveils india’s first study demonstrating the clinical impact of RNA-based NGS in sarcoma diagnosis

RNA sequencing improves sarcoma diagnosis by detecting gene fusions and refining classifications, enabling more accurate treatment decisions and better patient...

Multi-Omics Predicts 17 UK Biobank Diseases

In a groundbreaking study set to redefine the future of medical diagnostics and predictive healthcare, researchers have unveiled a powerful new methodology that leverages the compl...

New FDA recommendations support next-generation sequencing-based safety evaluation of off-target editing for personalise...

FDA draft guidance highlights next-generation sequencing approaches for evaluating off-target effects and genomic integrity in genome editing therapies, supporting safer gene thera...

Foundation Medicine links with Fulgent Genetics to offer new gene test

Roche’s Foundation Medicine has linked with Fulgent Genetics to offer a new diagnostic test that identifies a person’s genetic makeup that can determine how they metabolize and pro...

Next-generation sequencing has had a huge impact on molecular pathology lab

RNA sequencing and next generation sequencing expand cancer diagnostics by enabling multi gene analysis, improving mutation detection, and supporting targeted therapy decisions in...

Precision Medicine’s Next Hurdle Isn’t Science — It’s Execution

A new UPMC report found that while most health systems now offer precision medicine programs, many still face challenges scaling them due to reimbursement, data integration and pat...

Building the Genome Grid

MGI Tech’s decade-long push helped turn sequencing into scalable, affordable global infrastructure. The post Building the Genome Grid appeared first on GEN - Genetic Engineering an...

Genomic testing for advanced cancer improving but still lags

Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Ra...

Advancing Fully Walkaway Automation in Genomics Workflows

EMBL GeneCore plans to expand facility capacity to develop new protocols and further validate and optimize existing workflows for applications such as low-input and metagenomics sa...

UMass Chan Scientists Pioneer Gene Editing Technology That Rewrites Entire Genome Chapters

Scientists at UMass Chan Medical School have pioneered a groundbreaking gene editing technology named “prime assembly,” which challenges the limitations of traditional genome editi...

<![CDATA[Expanding Access to Whole-Genome Testing for Children: Q&A with Drs. Ryan Taft and Stacy Musone]]>

HealthEx and 23andMe Partner to Unify Medical Records and Genomics

What You Should Know Consumer identity and health data platform HealthEx has partnered with 23andMe to allow users to securely link their comprehensive electronic medical records d...

Personalised Medicine is the Buzz Word…but where is it in MS?

Personalized medicine has been a mantra for some years but in many cases this is just a pipedream. Personalization means screening to do selection and this equates to cost. It also...

The State of Multiomics & NGS

In our April 29 virtual summit GEN invites you to watch a superb line-up of presenters covering key topics in the world of multiomics, spatial biology, and NGS. The post The State...

Genomics inks partnership deal with Greywolf to assess gene datasets

Genomics inked a partnership deal with fellow U.K.-based biotech Greywolf Therapeutics to organize and evaluate ERAP enzymes and how they influence autoimmune disease risks.

Precision xenogenomics: a major milestone in bridging the organ gap